Skip to main content
. 2019 Feb;18(2):152–156.

Table 2.

Outcome of the included patients

Outcome Sodium chloride group (n=15) Placebo group (n=15) P-value
Incidence of VAP, no. (%) 4(26.6) 7(47) 0.2
Duration of mechanical ventilation, days (med ± IQR) 10±3 12±4 0.314
Length of ICU stay, days (med ± IQR) 21±14 23±11 0.803
ICU mortality, no.(%) 4(26.7) 3(20) 1

Statistically significant difference between groups (P < 0.05).

med: median IQR: interquantile range

VAP: Ventilator-associated pneumonia

ICU: intensive care unit